A Blood Test for Brain Cancer with a Dash of AI Added

Researchers from the University of Strathclyde have developed a blood test that could help to accelerate the diagnosis of brain cancer. The technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer.

This research is being commercialized by ClinSpec Diagnostics Ltd, a company spun out from the university in February 2019.